Advertisement
Screener

ONCOLYTICS BIOTECH INC. (ONCY) Noncurrent Contract Liabilities

2.8 / 5 stars · 68/120 Roast Me

ONCOLYTICS BIOTECH INC. Noncurrent Contract Liabilities

ONCOLYTICS BIOTECH INC. (ONCY) had Noncurrent Contract Liabilities of CAD 6.73 million as of 2024-12-31, per its 20-F filed 2025-03-07.

Financial Statements › Notes

ifrs-full:NoncurrentContractLiabilities · last filed 2025-03-07

  • 2024-12-31: Noncurrent Contract Liabilities 6.73M CAD.
  • 2023-12-31: Noncurrent Contract Liabilities 6.73M CAD.
  • 2022-12-31: Noncurrent Contract Liabilities 6.73M CAD.
  • 2021-12-31: Noncurrent Contract Liabilities 6.73M CAD; Noncurrent Contract Liabilities as first filed 6.73M CAD.

CAD

Period endNoncurrent Contract LiabilitiesNoncurrent Contract Liabilities as first filed
2024-12-316.73M CAD
20-F · filed 2025-03-07
2023-12-316.73M CAD
20-F · filed 2025-03-07
2022-12-316.73M CAD
20-F · filed 2024-03-12
2021-12-316.73M CAD
20-F · filed 2023-03-03
6.73M CAD
20-F · filed 2022-03-03
2020-12-316.73M CAD
20-F · filed 2022-03-03
2019-12-316.73M CAD
20-F · filed 2021-03-05
2018-12-315.80M CAD
20-F · filed 2020-03-06
2017-12-314.64M CAD
20-F · filed 2019-03-15
2016-12-310.00 CAD
20-F · filed 2018-03-19

USD

Period endNoncurrent Contract Liabilities
2017-12-31$4.64M
20-F · filed 2018-03-19
2016-12-31$0.00
20-F · filed 2018-03-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Rallybio Corp (RLYB)United States$0.089B
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30